Camilla Crompton

HeliosX is building the future of digital healthcare; one that is faster, more human, and radically more accessible. Founded in 2013, we set out to remove friction from accessing prescription medications; bringing speed, simplicity and trust to an industry that hadn’t kept pace. Today, HeliosX is the UK market leader, tripling our revenue in 2025, serving millions of customers, and operating across four markets; UK, US, Germany and Canada. We have achieved this without external funding; we're completely bootstrapped, profitable, and scaling sustainably. Through asynchronous telemedicine, intelligent technology, and vertically integrated care, we remove friction from the healthcare journey; no unnecessary GP visits, no pharmacy queues, no opaque processes. Just safe, effective treatment, delivered simply and discreetly. Every clinical decision is underpinned by medical rigour. Our treatments are prescribed and overseen by registered doctors and pharmacists, combining deep clinical expertise with modern digital delivery to earn long-term trust from our customers. With a team of c. 1,000 people and ambitions that match our pace - many new international markets, new conditions, and new ways of delivering care - HeliosX is entering its next chapter of growth in 2026. Our mission remains the same: to make healthcare work better for everyone, at scale, and for the long term.